Sector consensus Harvard Bioscience, Inc.
Stocks
HBIO
US4169062043
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 7.080 USD | +1.58% |
|
+15.50% | +5.86% |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 7.5 | +7.6% | 1 | ||||
| 631.42 | +7.2% | 26 | ||||||
| 227.96 | +14.22% | 23 | ||||||
| 478.01 | +22.2% | 30 | ||||||
| 62.69 | +24.21% | 29 | ||||||
| 100.96 | +10.97% | 26 | ||||||
| 45.1 | +14.28% | 20 | ||||||
| 160.11 | +7.86% | 19 | ||||||
| 436 | +8.66% | 23 | ||||||
| 82.5 | +13.59% | 18 | ||||||
| 247.2 | +12.37% | 15 | ||||||
| 198.89 | +5.63% | 19 | ||||||
| 232.51 | +54.44% | 18 | ||||||
| 27 | +14.92% | 20 | ||||||
| 2,034.62 | -3.85% | 13 | ||||||
| 121.07 | +6.43% | 15 | ||||||
| 58.75 | +3.32% | 12 | ||||||
| 10.58 | +41.07% | 5 | ||||||
| 121.8 | -2.63% | 5 | ||||||
| Average | 278.14 | +13.82% | 18 | ||||||
| Weighted average by Cap. | 345.28 | +14.24% | 24 |
- Stock Market
- Stocks
- HBIO Stock
- Sector Harvard Bioscience, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
